Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.

Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, Yang H, Carbone M.

Carcinogenesis. 2015 Jan;36(1):76-81. doi: 10.1093/carcin/bgu227. Epub 2014 Nov 7.

2.

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.

Leblay N, Leprêtre F, Le Stang N, Gautier-Stein A, Villeneuve L, Isaac S, Maillet D, Galateau-Sallé F, Villenet C, Sebda S, Goracci A, Byrnes G, McKay JD, Figeac M, Glehen O, Gilly FN, Foll M, Fernandez-Cuesta L, Brevet M.

J Thorac Oncol. 2017 Apr;12(4):724-733. doi: 10.1016/j.jtho.2016.12.019. Epub 2016 Dec 27.

3.

Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.

Rusch A, Ziltener G, Nackaerts K, Weder W, Stahel RA, Felley-Bosco E.

Lung Cancer. 2015 Jan;87(1):77-9. doi: 10.1016/j.lungcan.2014.10.017. Epub 2014 Nov 6.

PMID:
25468148
4.

Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.

Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B.

Ann Oncol. 2013 Aug;24(8):2147-50. doi: 10.1093/annonc/mdt135. Epub 2013 Apr 12.

PMID:
23585512
5.

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.

Zauderer MG, Bott M, McMillan R, Sima CS, Rusch V, Krug LM, Ladanyi M.

J Thorac Oncol. 2013 Nov;8(11):1430-3. doi: 10.1097/JTO.0b013e31829e7ef9.

6.

Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.

Kittaneh M, Berkelhammer C.

J Transl Med. 2018 Jul 13;16(1):194. doi: 10.1186/s12967-018-1559-7.

7.

Risk of second primary cancers after malignant mesothelioma and vice versa.

Chen T, Kharazmi E, Lou J, Zhang X, Sundquist K, Hemminki K.

Cancer Lett. 2016 Aug 28;379(1):94-9. doi: 10.1016/j.canlet.2016.05.034. Epub 2016 May 31.

PMID:
27260871
8.

Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.

Ohar JA, Cheung M, Talarchek J, Howard SE, Howard TD, Hesdorffer M, Peng H, Rauscher FJ, Testa JR.

Cancer Res. 2016 Jan 15;76(2):206-15. doi: 10.1158/0008-5472.CAN-15-0295. Epub 2015 Dec 30. Erratum in: Cancer Res. 2017 Jun 1;77(11):3124. Cancer Res. 2018 Jan 1;78(1):309.

9.

Germline BAP1 mutations predispose to malignant mesothelioma.

Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M.

Nat Genet. 2011 Aug 28;43(10):1022-5. doi: 10.1038/ng.912.

10.

BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival.

Bahnasy AA, El-Din RS, Sabri NA, Abdel-Rahman CA, Bastawisy AE.

Cancer Genet. 2018 Dec;228-229:83-92. doi: 10.1016/j.cancergen.2018.10.001. Epub 2018 Oct 8.

PMID:
30553477
11.

Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.

Sneddon S, Leon JS, Dick IM, Cadby G, Olsen N, Brims F, Allcock RJ, Moses EK, Melton PE, de Klerk N, Musk AW, Robinson BW, Creaney J.

Gene. 2015 May 25;563(1):103-5. doi: 10.1016/j.gene.2015.03.031. Epub 2015 Mar 18.

12.

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.

Alakus H, Yost SE, Woo B, French R, Lin GY, Jepsen K, Frazer KA, Lowy AM, Harismendy O.

J Transl Med. 2015 Apr 16;13:122. doi: 10.1186/s12967-015-0485-1.

13.

Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.

Betti M, Casalone E, Ferrante D, Romanelli A, Grosso F, Guarrera S, Righi L, Vatrano S, Pelosi G, Libener R, Mirabelli D, Boldorini R, Casadio C, Papotti M, Matullo G, Magnani C, Dianzani I.

Genes Chromosomes Cancer. 2015 Jan;54(1):51-62. doi: 10.1002/gcc.22218. Epub 2014 Sep 18.

PMID:
25231345
14.

Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.

Wiesner T, Fried I, Ulz P, Stacher E, Popper H, Murali R, Kutzner H, Lax S, Smolle-Jüttner F, Geigl JB, Speicher MR.

J Clin Oncol. 2012 Nov 10;30(32):e337-40. doi: 10.1200/JCO.2011.41.2965. Epub 2012 Oct 1. No abstract available.

PMID:
23032617
15.

BAP1 protein is a progression factor in malignant pleural mesothelioma.

Arzt L, Quehenberger F, Halbwedl I, Mairinger T, Popper HH.

Pathol Oncol Res. 2014 Jan;20(1):145-51. doi: 10.1007/s12253-013-9677-2. Epub 2013 Aug 22.

PMID:
23963927
16.

Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.

Betti M, Aspesi A, Ferrante D, Sculco M, Righi L, Mirabelli D, Napoli F, Rondón-Lagos M, Casalone E, Vignolo Lutati F, Ogliara P, Bironzo P, Gironi CL, Savoia P, Maffè A, Ungari S, Grosso F, Libener R, Boldorini R, Valiante M, Pasini B, Matullo G, Scagliotti G, Magnani C, Dianzani I.

Genes Chromosomes Cancer. 2018 Nov;57(11):573-583. doi: 10.1002/gcc.22670.

PMID:
30338612
17.

Puzzling Results from BAP1 Germline Mutations Analysis in a Group of Asbestos-Exposed Patients in a High-risk Area of Northeast Italy.

Rizzardi C, Athanasakis E, Cammisuli F, Monego SD, DE Spelorzi YCC, Costantinides F, Giudici F, Pinamonti M, Canzonieri V, Melato M, Pascolo L.

Anticancer Res. 2017 Jun;37(6):3073-3083.

PMID:
28551647
18.

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.

Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores EG, Kendrick B, Lapid D, Powers A, Kanodia S, Pastorino S, Pass HI, Dixit V, Yang H, Carbone M.

Oncogene. 2016 Apr 14;35(15):1996-2002. doi: 10.1038/onc.2015.243. Epub 2015 Jun 29.

19.

Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.

Betti M, Casalone E, Ferrante D, Aspesi A, Morleo G, Biasi A, Sculco M, Mancuso G, Guarrera S, Righi L, Grosso F, Libener R, Pavesi M, Mariani N, Casadio C, Boldorini R, Mirabelli D, Pasini B, Magnani C, Matullo G, Dianzani I.

Cancer Lett. 2017 Oct 1;405:38-45. doi: 10.1016/j.canlet.2017.06.028. Epub 2017 Jul 4.

20.

Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.

Joseph NM, Chen YY, Nasr A, Yeh I, Talevich E, Onodera C, Bastian BC, Rabban JT, Garg K, Zaloudek C, Solomon DA.

Mod Pathol. 2017 Feb;30(2):246-254. doi: 10.1038/modpathol.2016.188. Epub 2016 Nov 4.

Supplemental Content

Support Center